Apollo, Blackstone Fund AI Boom

Apollo and Blackstone are reportedly teaming up on a $35 billion AI financing deal, signaling a new funding model for costly AI infrastructure and chips. The structure could help unlock capital for AI buildout and may create an entirely new investment category, with Anthropic and Broadcom cited as relevant counterparties in the ecosystem. The news is supportive for AI infrastructure financing and may be sector-moving for alternative asset managers, chip suppliers, and AI data center buildouts.

Analysis

This is less about one financing package and more about the creation of a new asset class: compute-capacity lending. If this structure works, capital will increasingly be priced against contracted AI usage rather than against the balance sheet of any single hyperscaler, which should compress financing costs for the strongest ecosystem players and widen the gap versus smaller AI builders that lack scale or bankability. That dynamic is structurally positive for BX because it monetizes its origination, structuring, and placement edge in a market where private-credit underwriting standards are still being invented.

The second-order effect is on chip demand durability. By shifting upfront chip economics into financed infrastructure, demand becomes less sensitive to near-term capex pauses and more dependent on long-dated utilization assumptions, which supports AVGO indirectly through a more reliable order book and better visibility for adjacent AI networking and custom silicon. The risk is that this turns into a maturity-mismatch trade if utilization ramps slower than expected; in that case, the market may initially celebrate the deal formation but later punish the lenders and beneficiaries when residual values and refinancing terms come into question.

The consensus is probably underestimating how quickly this could pull in insurers, sovereign funds, and pension capital once the first structure is validated. That’s bullish for spread compression in the near term, but it also means returns on the financing leg may be front-loaded and then normalized as competition floods in over the next 6-18 months. The real contrarian watchpoint is whether these deals become a substitute for organic demand growth: if financing is propping up deployments faster than end-user monetization, the market will eventually reprice the whole AI infra stack.

From a trading perspective, BX is the cleaner expression for the structural winner because the upside is less dependent on any single project’s economics and more on fee wallet expansion across a new category. AVGO is a lower-beta beneficiary, but it should trade better on confirmation that this mechanism improves long-duration visibility for AI infrastructure spending rather than just shifting leverage around the system.

Key Decisions for Investors

• Long BX on a 3-6 month horizon; use pullbacks to build a starter position. Risk/reward favors multiple expansion if the market starts assigning franchise value to AI-finance origination, with downside limited unless the first deals show underwriting stress.
• Add AVGO on weakness over the next 1-2 weeks; treat this as a visibility trade rather than a catalyst trade. Upside comes from improved AI capex durability, while the main risk is that financing headlines fade without changing ordering trends.
• Pair trade: long BX / short a basket of slower-growing regional banks with weak fee income exposure. The thesis is that specialized private-market structuring should capture the higher-margin economics of AI financing before traditional lenders can compete.
• Buy medium-dated BX call spreads if the market is willing to pay for the emergence of a new product cycle. This captures upside if additional deals print over the next quarter, while capping premium outlay if the theme stalls.
• Set a risk trigger on AVGO if AI infrastructure financing starts widening secondary spreads or prompting rating agency scrutiny; that would signal the market is beginning to question residual values and could reverse the positive read-through within 3-6 months.